Hartline Investment Corp’s Pfizer PFE Stock Holding History

Hartline Investment Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,180	Closed	-$201K	–	104
2024 Q2	$201K	Sell	7,180 -59,204	-89%	-$1.63M	0.03%	99
2024 Q1	$1.84M	Buy	+66,384	New	+$1.84M	0.32%	71
2022 Q4	–	Sell	-11,798	Closed	-$516K	–	171
2022 Q3	$516K	Buy	+11,798	New	+$573K	0.43%	47
2019 Q2	–	Sell	-5,419	Closed	-$218K	–	115
2019 Q1	$218K	Hold	5,419	–	–	0.06%	105
2018 Q4	$224K	Buy	+5,419	New	+$225K	0.07%	106
2015 Q2	–	Sell	-6,219	Closed	-$205K	–	109
2015 Q1	$205K	Buy	+6,219	New	+$198K	0.07%	106
2014 Q2	–	Sell	-6,788	Closed	-$207K	–	111
2014 Q1	$207K	Buy	+6,788	New	+$202K	0.07%	105

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hartline Investment Corp's PFE Position: Q3 2024 in Review

Hartline Investment Corp sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,180 shares — an estimated $201K sold.

Hartline Investment Corp first reported a position in PFE in Q1 2014 and held it in 7 quarters. The position peaked at $1.84M in Q1 2024. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Hartline Investment Corp reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Hartline Investment Corp sold 7,180 Pfizer shares in Q3 2024, an estimated $201K.
Hartline Investment Corp first reported a position in Pfizer in Q1 2014 and held it in 7 quarters.
Hartline Investment Corp's Pfizer position peaked at $1.84M in Q1 2024.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Hartline Investment Corp's 13F filing for Q3 2024, filed 5 Nov 2024.